Designs for studying the effectiveness of long-term psychoanalytic treatments: balancing level of evidence and acceptability to patients

Journal of the American Psychoanalytic Association
Frans de JongheJack Dekker

Abstract

Long-Term Psychoanalytic Treatments (LTPT) include both long-term psychoanalytic psychotherapy (LTPP) and psychoanalysis (PsAn). Current opinion seems to be that there is some evidence for the effectiveness of LTPP, but none for that of PsAn. This may be due in part to researchers not balancing the level of evidence of randomized controlled studies (RCTs), cohort studies, and pre-post studies with patients' acceptance of these various research designs used in studying the effectiveness of LTPT. After a review of the merits of eight possible control conditions for LTPT in RCTs and cohort studies, and a consideration of the limitations and merits of pre-post studies, it was found that RCTs pair high levels of evidence with limited degrees of patient acceptance, especially where PsAn is concerned. Cohort studies appear to provide at most a moderate level of evidence. Their acceptability is hardly better than that of RCTs, as it depends on the acceptability of control conditions similar to those of RCTs. The acceptability of pre-post studies is much better, but they can provide, at most, a moderate level of evidence. Apart from randomization, they can meet all methodological criteria for high-quality research (often they do not, bu...Continue Reading

References

Jan 11, 1991·Journal of the American Psychoanalytic Association·H M BachrachS Waldron
Dec 1, 1991·Archives of General Psychiatry·M M LinehanH L Heard
Feb 1, 1982·The American Journal of Medicine·H SacksH Smith
Dec 1, 1993·Archives of General Psychiatry·M M LinehanH E Armstrong
Jan 13, 1996·BMJ : British Medical Journal·D L SackettW S Richardson
Jun 22, 2000·The New England Journal of Medicine·K Benson, A J Hartz
Jun 22, 2000·The New England Journal of Medicine·J ConcatoR I Horwitz
Mar 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·C DareL Dodge
Jun 5, 2002·Archives of General Psychiatry·Glen O GabbardPeter Fonagy
Sep 11, 2002·Journal of the American Psychoanalytic Association·Norman DoidgePaul Mosher
Mar 28, 2003·Journal of Personality Disorders·Simone KoolBarteld Puite
May 7, 2003·Journal of the American Psychoanalytic Association·Joan B Erle, Daniel A Goldberg
Jul 9, 2004·Journal of Personality Disorders·Gregory K BrownAaron T Beck
Aug 15, 2006·Comprehensive Psychiatry·Anthony KornerJanine Stevenson
Feb 14, 2007·Journal of Consulting and Clinical Psychology·Brian M IacovielloJacques P Barber
Oct 2, 2008·JAMA : the Journal of the American Medical Association·Falk Leichsenring, Sven Rabung
Nov 8, 2008·Bulletin of the Menninger Clinic·Caspar C Berghout, Jolien Zevalkink
Feb 12, 2009·Harvard Review of Psychiatry·Saskia de MaatJack Dekker
Feb 12, 2009·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Jacques P Barber
Apr 28, 2009·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Henricus L VanRobert Schoevers
Jun 17, 2009·Journal of the American Psychoanalytic Association·Eve CaligorSteven P Roose
Sep 22, 2009·Clinical Psychology Review·Ellen DriessenJack J M Dekker
Jan 12, 2010·International Journal of Technology Assessment in Health Care·Caspar C BerghoutLeona Hakkaart-van Roijen
Mar 16, 2011·Psychotherapy·Adam O HorvathDianne Symonds
May 15, 2012·Journal of the American Psychoanalytic Association·Eve CaligorSteven P Roose

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

PsAn

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.